Ophthotech

Ophthotech <![CDATA[arc1905_home.jpg]]> <![CDATA[e10030_home.jpg]]> <![CDATA[volociximab_home.jpg]]> <![CDATA[6. ARC1905 inhibits C5-mediated inflammatory and MAC activities]]> <![CDATA[5. VEGF promotes angiogenesis]]> <![CDATA[4. C5a stimulates VEGF and other growth factor production]]> <![CDATA[3. MAC initiates RPE lysis]]> <![CDATA[2. Membrane Attack Complex (MAC)]]> <![CDATA[1. C5 cleaves into C5a and C5b]]> <![CDATA[5. Combination therapy results in CNV regression]]>